Amfepramone

Nobesine 75 Sustained Release Capsule 75MG

75 MG Capsule (Sustained-Release)CanadaCancelledAuthorised 31 Dec 1978

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

REGENON 25 mgRomania · 25mg · caps. moi · Temmler Pharma GMBHSame form
Diethylpropion HydrochlorideUnited States · 25MG · tablet · TevaSame substance
Diethylpropion HydrochlorideUnited States · 75MG · tablet, extended release · Lannett Co INCSame substance
TenuateUnited States · 25MG, 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet · MPP PharmaSame substance

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Amfepramone

Nobesine 75 Sustained Release Capsule 75MG

75 MG Capsule (Sustained-Release)CanadaCancelledAuthorised 31 Dec 1978

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Amfepramone
Strength: 75 MG
Dosage form: Capsule (Sustained-Release)
Route: Oral
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 31 Dec 1978
Registration: DIN 00779490
Marketing authorisation holder: Rougier Pharma Division of Ratiopharm INC
ATC code: A08AA03
Group: Alimentary tract and metabolism
Supply: CONTROLLED DRUGS (CDSA IV)